Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)

Código QR

Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)

Aim. To analyse factors hampering the achievement of compensation of carbohydrate metabolism in patients with type 2 diabetes mellitus treated for3 months with diabeton MB at a daily dose of 90-120 mg under real practical conditions. Materials and methods. This open study included 70 patients with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina Evgen'evna Sapozhnikova, Elena Nikolaevna Anufrieva, Ekaterina Iosifovna Tarlovskaya, Alexander Anatol'evich Sobolev
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2010
Materias:	type 2 diabetes mellitus hypoglycemic therapy gliclazide mb hba1c level Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/6518a7cf4b174f3bac0972ff6d4a4961
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hypoglycemic therapy in patients on hemodialysis and peritoneal dialysis
por: Irina Arkad'evna Bondar', et al.
Publicado: (2010)

Pharmacogenetics of hypoglycemic agents
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2015)

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
por: I. V. Kononenko, et al.
Publicado: (2021)

Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2010)

Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011)

Analysis of typical approaches to outpatient management of type 2 diabetes mellitus
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2012)

Drug-drug Interactions between Hypoglycemic and Non-hypoglycemic Medication in Diabetic Patients with Comorbidities in a Tertiary Care Center: A Descriptive Cross-sectional Study
por: Lujaw Ratna Tuladhar, et al.
Publicado: (2021)

Dynamics of myocardial necrosis biomarkers and acid-base balance parameters after coronary artery bypass grafting on beating-heart depending on the perioperative glucose-lowering treatment regimen in patients with type II diabetes
por: S. Y. Borodashkina, et al.
Publicado: (2015)

Epidemiology of diabetes mellitus and prognosis of its prevalence in the Russian Federation
por: Yury Ivanovich Suntsov, et al.
Publicado: (2011)

Influence of hyperinsulinemic – hypoglycemic clamp on induced platelet aggregation, activity of physiological anticoagulants and von Willebrand factor in patients with type I diabetes
por: Iwona R. Jarek-Martynowa, et al.
Publicado: (2018)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)

Time-Dependent Hypoglycemic and Hypolipidemic Effect of Allium Ascalonicum L. Feeding in Diabetic Rats
por: F Fallahi,, et al.
Publicado: (2010)

A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
por: Yury Shavkatovich Khalimov, et al.
Publicado: (2011)

Hypoglycemic activity and constituents analysis of blueberry (Vaccinium corymbosum) fruit extracts
por: Huang W, et al.
Publicado: (2018)

Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

SIMULTANEOUS DETERMINATION OF ROSIGLITAZONE AND GLICLAZIDE IN PHARMACEUTICAL DOSAGE FORMS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
por: LAKSHMI,K.S, et al.
Publicado: (2010)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
por: Alexander Sergeevich Ametov, et al.
Publicado: (2009)

Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010)

Hypoglycemic and antioxidant effect of Tai chi exercise training in older adults with metabolic syndrome
por: Mendoza-Núñez VM, et al.
Publicado: (2018)

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study
por: Nazief AM, et al.
Publicado: (2020)

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
por: Buchegger,Kurt, et al.
Publicado: (2016)

Sequential Extraction, Characterization, and Analysis of Pumpkin Polysaccharides for Their Hypoglycemic Activities and Effects on Gut Microbiota in Mice
por: Hui-qing Wu, et al.
Publicado: (2021)

Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes
por: Natalia Р. Trubitsyna, et al.
Publicado: (2019)

Effects of different drying methods on phenolic components and in vitro hypoglycemic activities of pulp extracts from two Chinese bayberry (Myrica rubra Sieb. et Zucc.) cultivars
por: Zhe Liu, et al.
Publicado: (2022)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
por: Marina V. Shestakova, et al.
Publicado: (2017)

Eficacia de los hipoglicemiantes orales en el control metabólico de pacientes con diabetes mellitus gestacional
por: Valdés R,Enrique, et al.
Publicado: (2008)

The results of open observational trial DIAMOND
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2011)

Cystatin C and collagen type IV in diagnostics of chronic kidney disease in type 2 diabetic patients
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2015)

Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Peculiarities of correction of sexual function in men presenting with diabetes mellitus
por: Roman Viktorovich Rozhivanov, et al.
Publicado: (2010)

Significance of HbA1c targets based on an individual approach to the treatment of patients with type 2 diabetes mellitus
por: Inna Vladimirovna Misnikova, et al.
Publicado: (2014)

Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
por: Nina A. Petunina, et al.
Publicado: (2020)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Ischaemic heart disease in patients with diabetes mellitus and critical lower limb ischemia
por: Konstantin Vladimirovich Melkozerov, et al.
Publicado: (2012)

Isolation of Breast Cancer Stem Cell from MDA-MB231 Cell Line Using Vincristine
por: Ghanbari,Tara, et al.
Publicado: (2016)

Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016)
por: Alexander Y. Mayorov, et al.
Publicado: (2018)

Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
por: Alina Y. Babenko, et al.
Publicado: (2018)

In memory of Vitaly R. Klyachko
por: Maryana Evgen'evna Kutuzova
Publicado: (2014)

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
por: Qi Zheng, et al.
Publicado: (2021)